Key Highlights AI Proteins partners with Bristol Myers Squibb to develop novel miniprotein-based therapies. Collaboration includes an upfront payment and…
Key Highlights Catherine Owen Adams appointed CEO, succeeding Steve Davis. Adams brings extensive global experience from Bristol Myers Squibb and Johnson & Johnson.…